W hen Jenny, a 50-year-old marketing and branding professional from Cambridge, went for her shingles vaccine last year, an entirely different disease was on her mind.
The wave of work on the shingles vaccine was spurred by suspicions that the virus that causes chickenpox and shingles, varicella zoster virus or VZV, might somehow contribute to dementia.
“I thought wow, I’ll just book the vaccine online, ” says Todd.
Sally, a 68-year-old former headteacher in Telford, Shropshire, cared for her mother with dementia for five years.
Britain’s high street chemists have reported a rise in demand for the shingles vaccine, at least some of which is driven by people mor.